Paculaba, Amira Ellise L.
HRN: 21-97-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2022
AMPICILLIN 1GM (VIAL)
09/28/2022
10/06/2022
IVTT
250mg
Q6
Infectious Gastroenteritis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes